The latest data point for CVS's operating ROA metrics in Q4'25 shows ROE at 3.91%, ROA at 1.16%, and ROIC at 2.40%, indicating a strong recovery from the negative values observed in the prior quarter. This uptick suggests improved operational efficiency and profitability at year-end, with ROIC leading the rebound among the three indicators. Over the period from Q1'23 to Q4'25, the ROE, ROA, and ROIC lines exhibit overall volatility with a general downward trend until a sharp decline in Q3'25—where ROE dropped to -5.45%, ROA to -1.56%, and ROIC to -2.06%—followed by a robust recovery in Q4'25. Key patterns include stable but low single-digit percentages in 2023 (e.g., ROA averaging around 0.8%), a notable dip in Q1'24 and Q3'24, and escalating pressures in 2025 leading to the Q3 negative inflection point, highlighting potential challenges in asset utilization and capital efficiency before the end-of-year improvement.